JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$3.58B |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$2.7B |
| 3 |
Apple
AAPL
|
+$1.71B |
| 4 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.57B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.51B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.51B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$920M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$817M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$794M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.23% |
| 2 | Technology | 15.68% |
| 3 | Financials | 11.13% |
| 4 | Consumer Discretionary | 9.78% |
| 5 | Healthcare | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
IVAC
4626
DELISTED
Intevac Inc
IVAC
| $422K | ﹤0.01% |
62,586
-16,375
| -21% | -$106K |
2017 Q4
14 quarters
|
|
|
LUNA
4627
DELISTED
Luna Innovations Incorporated
LUNA
| $422K | ﹤0.01% |
38,981
-44,202
| -53% | -$481K |
2020 Q2
4 quarters
|
|
4628
CALL
Domino's
DPZ
$9.76B
| $420K | ﹤0.01% |
900
| – | – |
2021 Q1
1 quarter
|
|
4629
SkinHealth Systems
SKIN
$82M
| $419K | ﹤0.01% |
24,982
-104,944
| -81% | -$1.44M |
2020 Q4
2 quarters
|
|
4630
PUT
Coupang
CPNG
$24.8B
| $418K | ﹤0.01% |
+10,000
| New | +$409K |
2021 Q2
0 quarters
|
|
4631
Phathom Pharmaceuticals
PHAT
$573M
| $418K | ﹤0.01% |
12,345
-182,029
| -94% | -$6.52M |
2019 Q4
6 quarters
|
|
4632
Uranium Energy
UEC
$4.64B
| $417K | ﹤0.01% |
156,693
-548,213
| -78% | -$1.65M |
2016 Q1
21 quarters
|
|
4633
IDEAYA Biosciences
IDYA
$3.65B
| $416K | ﹤0.01% |
19,837
-12,013
| -38% | -$247K |
2020 Q2
4 quarters
|
|
4634
Pure Cycle
PCYO
$262M
| $416K | ﹤0.01% |
30,065
-19,985
| -40% | -$286K |
2017 Q4
14 quarters
|
|
|
NWLI
4635
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $415K | ﹤0.01% |
1,851
-3,834
| -67% | -$914K |
2016 Q4
18 quarters
|
|
|
CURO
4636
DELISTED
CURO Group Holdings Corp.
CURO
| $415K | ﹤0.01% |
24,378
-5,291
| -18% | -$82.2K |
2018 Q1
13 quarters
|
|
4637
PUT
Compugen
CGEN
$222M
| $414K | ﹤0.01% |
50,000
| – | – |
2021 Q1
1 quarter
|
|
4638
PUT
Invesco
IVZ
$13.4B
| $414K | ﹤0.01% |
15,500
+9,000
| +138% | +$245K |
2021 Q1
1 quarter
|
|
|
KRNLU
4639
DELISTED
Kernel Group Holdings, Inc. Units
KRNLU
| $414K | ﹤0.01% |
40,476
| – | – |
2021 Q1
1 quarter
|
|
|
TDAY
4640
CALL
USA Today Co
TDAY
$1.04B
| $412K | ﹤0.01% |
75,000
| – | – |
2021 Q1
1 quarter
|
|
|
ONIT
4641
Onity Group
ONIT
$230M
| $411K | ﹤0.01% |
13,272
+13,216
| +23,600% | +$402K |
2021 Q1
1 quarter
|
|
4642
Flexsteel Industries
FLXS
$354M
| $409K | ﹤0.01% |
10,142
+10,133
| +112,589% | +$442K |
2017 Q4
14 quarters
|
|
|
AESC
4643
DELISTED
The AES Corporation
AESC
| $409K | ﹤0.01% |
+3,803
| New | +$402K |
2021 Q2
0 quarters
|
|
4644
Peoples Financial Services
PFIS
$682M
| $408K | ﹤0.01% |
9,563
-12,197
| -56% | -$525K |
2017 Q4
14 quarters
|
|
4645
OptimizeRx
OPRX
$158M
| $407K | ﹤0.01% |
6,575
+435
| +7% | +$22.1K |
2018 Q4
10 quarters
|
|
|
MRSN
4646
DELISTED
Mersana Therapeutics
MRSN
| $405K | ﹤0.01% |
1,194
-4,493
| -79% | -$1.7M |
2017 Q2
16 quarters
|
|
|
EGLX
4647
DELISTED
Enthusiast Gaming Holdings Inc. Common Stock
EGLX
| $405K | ﹤0.01% |
+68,189
| New | +$464K |
2021 Q2
0 quarters
|
|
4648
Distribution Solutions Group
DSGR
$1.62B
| $404K | ﹤0.01% |
15,098
-12,446
| -45% | -$343K |
2016 Q4
18 quarters
|
|
4649
Harvard Bioscience
HBIO
$37M
| $404K | ﹤0.01% |
4,856
-7,013
| -59% | -$496K |
2019 Q4
6 quarters
|
|
4650
Talphera
TLPH
$58.1M
| $402K | ﹤0.01% |
14,569
+8,143
| +127% | +$218K |
2019 Q2
8 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2021 Portfolio in Review
As of Q2 2021, JP Morgan Chase held 6,872 positions worth $838B, up 12% from $749B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase deployed $31.1B of net new capital in Q2 2021, opening 693 new positions and adding to 2,351 existing holdings. Its largest new stake was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 25,313,889 shares worth $358M.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $1.51B trimmed.
- JP Morgan Chase's largest Q2 2021 buy was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 25,313,889 shares worth $358M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2021, an estimated $3.58B increase.
- JP Morgan Chase's biggest Q2 2021 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $1.51B.
- JP Morgan Chase fully exited INPHI CORPORATION in Q2 2021, selling an estimated $333M.
- JP Morgan Chase's ten largest holdings make up 16% of its $838B portfolio in Q2 2021.
- JP Morgan Chase opened 693 new positions and closed 449 in Q2 2021.
- JP Morgan Chase's portfolio value rose 12% quarter-over-quarter to $838B.
Based on JP Morgan Chase's 13F filing for Q2 2021, filed 12 Aug 2021.